Technical Report Dermatology Integrative/Complementary Medicine
Rethinking time to diagnosis in older adults: the role of an antibiotic stewardship programme

Rethinking time to diagnosis in older adults: the role of an antibiotic stewardship programme

Authors

Lucas Tanaka

Lucas Tanaka

Aga Khan University Hospital, Benin

Tariq Farouk

Tariq Farouk

Hamad Medical Corporation, South Georgia

Malik Kaur

Malik Kaur

Aga Khan University Hospital, New Caledonia

Ines Herrera

Ines Herrera

Singapore General Hospital, Mali

Corresponding

Published

September 16, 2024

Paper ID

PAP-000124

Status

Published

DOI

10.65712/tmj.test000382

Rethinking time to diagnosis in older adults: the role of an antibiotic stewardship programme

Advance Services

Create Content

Video • Presentation • Poster

From $97.00 per format

Abstract

Background: Practice around an antibiotic stewardship programme varies widely between centres. Methods: Eligible participants were older adults. Results: Effects were consistent across prespecified subgroups. Serious adverse events were rare and similar between groups. Conclusion: Strengths include the sample size and blinded outcome assessment.

Introduction

time to diagnosis remains a leading cause of avoidable harm among older adults. The cost of time to diagnosis to health systems is substantial. Practice around an antibiotic stewardship programme varies widely between centres.

Earlier studies of an antibiotic stewardship programme were small or single-centre. Practice around an antibiotic stewardship programme varies widely between centres.

Practice around an antibiotic stewardship programme varies widely between centres. time to diagnosis remains a leading cause of avoidable harm among older adults.

Discussion

Strengths include the sample size and blinded outcome assessment. Future work should test an antibiotic stewardship programme in a pragmatic multicentre trial. Residual confounding cannot be excluded.

Residual confounding cannot be excluded. Implementation will depend on staffing, cost and local protocols.

These findings suggest that an antibiotic stewardship programme is associated with better time to diagnosis in older adults. Strengths include the sample size and blinded outcome assessment.

These findings suggest that an antibiotic stewardship programme is associated with better time to diagnosis in older adults. Future work should test an antibiotic stewardship programme in a pragmatic multicentre trial.

Conclusions

An antibiotic stewardship programme is a reasonable option for older adults to improve time to diagnosis.

References

1. Moreau K, Herrera J, et al. High-flow nasal oxygen and surgical site infection. JAMA. 2023;375(11):347-1566.

2. Patel G, Okafor F, et al. Early mobilisation and acute kidney injury. Diabetes Care. 2010;251(1):645-1321.

3. Mensah K, Nakamura O, et al. Delayed cord clamping and 30-day readmission. JAMA. 2014;337(8):845-1333.

4. Lindqvist Q, Farouk J, et al. Home-based cardiac rehabilitation and 30-day readmission. N Engl J Med. 2024;94(9):711-1727.

5. Mensah N, Okafor S, et al. A sepsis alert system and 30-day readmission. JAMA. 2022;305(12):331-1442.

6. Herrera M, Costa J, et al. Nurse-led discharge planning and medication adherence. Pediatrics. 2019;345(2):462-1570.

7. Osei G, Mueller F, et al. Machine-learning triage and ventilator-free days. N Engl J Med. 2010;376(9):105-1553.

8. Mensah C, Ahmed O, et al. An antibiotic stewardship programme and falls. Crit Care Med. 2014;163(4):163-1505.

Appendices

Supplementary tables are available on request.

Materials and Methods

We conducted a multicentre observational study across 12 centres between 2017 and 2023. Analyses were adjusted for age, sex and baseline severity. The primary outcome was time to diagnosis, assessed blind to allocation. Missing data were handled with multiple imputation.

The primary outcome was time to diagnosis, assessed blind to allocation.

Eligible participants were older adults. Missing data were handled with multiple imputation. Analyses were adjusted for age, sex and baseline severity. The primary outcome was time to diagnosis, assessed blind to allocation.

Eligible participants were older adults. The primary outcome was time to diagnosis, assessed blind to allocation.

Results

The adjusted odds ratio was 0.73 (95% CI 0.40 to 0.94). time to diagnosis occurred in 20% of the intervention group versus 31% of controls. Serious adverse events were rare and similar between groups. The adjusted odds ratio was 0.56 (95% CI 0.24 to 0.90).

Effects were consistent across prespecified subgroups. 669 participants were included (median age 32 years). time to diagnosis occurred in 8% of the intervention group versus 29% of controls.

Effects were consistent across prespecified subgroups. time to diagnosis occurred in 16% of the intervention group versus 19% of controls. time to diagnosis occurred in 7% of the intervention group versus 36% of controls.

GroupnEventsRate %OR95% CI
Intervention553418.90.970.39–1.0
Centre B2509437.90.850.23–1.17
Male80011422.90.890.39–1.11
Age < 658262328.10.870.58–1.20
Female7831134.60.850.42–1.12
Female60911410.00.760.44–1.37
TABLE 1: Adverse events
Values are n (%) unless stated otherwise.
Figure 1
FIGURE 1: Forest plot of time to diagnosis
Shown for older adults; error bars are 95% confidence intervals.

Effects were consistent across prespecified subgroups. 4079 participants were included (median age 54 years).